Physician profile
Kierra Smith
NPI 1780272989
$4,456.76
in general payments reported to CMS, 2019-2025
36 companies · $64.17 in 2025
The $64.17 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,178 · 2022: $2,229 · 2023: $986 · 2025: $64.17.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,050.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,049.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $633.77 | 2021-2023 | Ozempic, Rybelsus, Wegovy |
| Abbvie INC. | $545.45 | 2021-2023 | |
| Lilly USA, LLC | $525.94 | 2021-2023 | Mounjaro, Jardiance, Emgality |
| Astrazeneca Pharmaceuticals LP | $449.95 | 2021-2023 | Farxiga |
| Pfizer INC. | $245.57 | 2021-2023 | |
| Amgen INC. | $230.83 | 2021-2023 | Otezla, Repatha |
| Amarin Pharma, INC. | $187.79 | 2021-2022 | |
| Upsher-Smith Laboratories LLC | $173.61 | 2021-2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $154.95 | 2021-2023 | |
| Biohaven Pharmaceutical Holding Company LTD. | $136.91 | 2022 | |
| Glaxosmithkline, LLC. | $128.04 | 2021-2023 | Trelegy Ellipta, Shingrix |
| Boehringer Ingelheim Pharmaceuticals, INC. | $123.77 | 2022-2023 | Jardiance, Glyxambi, Tradjenta |
| Lundbeck LLC | $115.73 | 2022-2023 | Rexulti |
| Dexcom, INC. | $114.45 | 2022-2023 | Dexcom G6 Transmitter |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $86.29 | 2022-2023 | Xifaxan |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $69.76 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $53.21 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $52.15 | 2021 | |
| Exact Sciences Corporation | $49.74 | 2023-2025 | Cologuard Collection Kit |
| Si-Bone, INC. | $45.73 | 2021-2023 | |
| Medline Industries LP | $37.24 | 2025 | |
| Althera Pharmaceuticals LLC | $31.16 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $31.03 | 2023 | Trintellix |
| Jazz Pharmaceuticals INC. | $30.97 | 2021 | |
| Shield Therapeutics INC | $24.00 | 2023 | Accrufer |
| Azurity Pharmaceuticals, INC. | $23.19 | 2023 | Horizant |
| Eisai INC. | $21.62 | 2022 | |
| Arbor Pharmaceuticals, INC. | $19.05 | 2021 | |
| Sanofi Pasteur INC. | $18.23 | 2022 | |
| Cranial Technologies, INC | $15.00 | 2021 | |
| Genentech USA, INC. | $14.81 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $14.68 | 2022 | |
| Nestle Healthcare Nutrition INC. | $13.93 | 2023 | |
| Paratek Pharmaceuticals, INC. | $13.20 | 2021 | |
| Antares Pharma, INC. | $12.78 | 2021 | |
| Astellas Pharma US INC | $12.23 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kierra Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.